1
项与 Hepatitis C vaccine(Cerus Corp.) 相关的临床试验A Phase 1/2 Randomized, Placebo-Controlled, Double-Blind, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Multiple Intravenous Doses of ANZ-521 in Hepatitis C Patients
The purpose of this study is to evaluate the safety, immunogenicity, and antiviral effects of multiple intravenous doses of ANZ-521 in patients with chronic Hepatitis C virus.
100 项与 Hepatitis C vaccine(Cerus Corp.) 相关的临床结果
100 项与 Hepatitis C vaccine(Cerus Corp.) 相关的转化医学
100 项与 Hepatitis C vaccine(Cerus Corp.) 相关的专利(医药)
100 项与 Hepatitis C vaccine(Cerus Corp.) 相关的药物交易